SCHEMBL6539232

SCHEMBL6539232

COC(=O)c1ccc(C(=O)Nc2ccc(C[C@@H](CO)N(C[C@H](O)c3cccc(Cl)c3)C(=O)OC(C)(C)C)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.52
ADRB3 P13945 11/20 0.43
ITGB1 P05556 1/20 0.42
ITGA4 P13612 1/20 0.42
ADRB1 P08588 9/20 0.42
ADRB2 P07550 3/20 0.40
SLC2A1 P11166 2/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GLA P06280 1/20 0.38
PLAU P00749 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6539237 1.00 BACE1 (0.52) BACE1ADRB3ITGB1ITGA4ADRB1
SCHEMBL6540024 0.82 BACE1 (0.53) BACE1ADRB3ITGB1ITGA4ADRB1
SCHEMBL6540029 0.82 BACE1 (0.53) BACE1ADRB3ITGB1ITGA4ADRB1
SCHEMBL6538935 0.82 BACE1 (0.54) BACE1ADRB3ADRB1ADRB2SLC2A1
SCHEMBL6539195 0.82 BACE1 (0.54) BACE1ADRB3ADRB1ADRB2SLC2A1
SCHEMBL6538940 0.82 BACE1 (0.54) BACE1ADRB3ADRB1ADRB2SLC2A1
Hydrochloric Acid SCHEMBL6538854 0.77 ADRB3 (0.68) ADRB3ADRB1ADRB2SLC2A1GLA
Hydrochloric Acid SCHEMBL6538857 0.77 ADRB3 (0.68) ADRB3ADRB1ADRB2SLC2A1GLA
SCHEMBL6478726 0.76 BACE1 (0.52) BACE1ADRB3ADRB1ADRB2SLC2A1
SCHEMBL6478721 0.76 BACE1 (0.52) BACE1ADRB3ADRB1ADRB2SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6826033-B2 BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
US-20040037022-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-02-26 US disclosed
WO-2002024635-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-28 WO disclosed